Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
Eighty canine epithelial colorectal tumors obtained by excisional biopsy were evaluated immunohistochemically for p53 tumor suppressor gene protein. Dogs in the study average 6.9 years of age (range, 1-12.5 years). A standard avidin-biotin immunohistochemical protocol incorporated a polyclonal antibody of rabbit origin (CM-1) as the primary antibody. Positive staining was observed within all subcategories of lesions, including hyperplastic polyps 1/2 (50%), adenomas 14/29 (48%), carcinomas in situ 9/22 (41%), adenocarcinomas 3/4 (75%), and invasive carcinomas 8/23 (35%). A total of 35/80 (44%) positive tumors wee identified. Fifteen of 31 (48%) benign tumors labeled for p53 protein compared to 20/49 (41%) malignant tumors. Survival data was available for 57/80 (71%) dogs. The average age of dogs within the group with survival data was 4.4 years. Males predominated 34/57 (60%). Mean survival time was 20.6 months. There was no significant difference in survival time between dogs grouped according to p53 immunoreactivity, cellular stain location, or tumor site. A statistically significant increase in survival time was observed between dogs with clean surgical margins and those without (P < 0.018) and for dogs with adenomas or carcinomas in situ over dogs with invasive carcinomas (P < 0.02). In this study, the overall greater positive staining frequency of benign lesions compared to malignant lesions is contrary to data derived from similar immunohistochemical analyses of human tumors and is incongruous with the theorized late-stage participation of the p53 protein in the development of human colorectal cancers. The results of this study suggest that if the p53 tumor suppressor gene protein is involved in the progression of canine colorectal tumors, it may play a relatively early role, possibly analogous to the early appearance of p53 overexpression in precancerous lesions of human ulcerative colitis. Immunohistochemical detection of p53 was not useful prognostically.
Wolf
J C
JC
Department of Pathobiology, College of Veterinary Medicine, University of Florida, Gainesville, USA.
Ginn
P E
PE
Homer
B
B
Fox
L E
LE
Kurzman
I D
ID
D000230:Adenocarcinoma / Q000737:chemistry / Q000473:pathology / Q000662:veterinary; D000236:Adenoma / Q000737:chemistry / Q000473:pathology / Q000662:veterinary; D000818:Animals; D002277:Carcinoma / Q000737:chemistry / Q000473:pathology / Q000662:veterinary*; D002278:Carcinoma in Situ / Q000737:chemistry / Q000473:pathology / Q000662:veterinary; D003111:Colonic Polyps / Q000737:chemistry / Q000473:pathology / Q000662:veterinary; D015179:Colorectal Neoplasms / Q000737:chemistry / Q000473:pathology / Q000662:veterinary*; D004283:Dog Diseases / Q000453:epidemiology / Q000378:metabolism* / Q000473:pathology; D004285:Dogs; D005260:Female; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic; D016147:Genes, Tumor Suppressor / Q000235:genetics*; D016158:Genes, p53 / Q000235:genetics*; D007150:Immunohistochemistry / Q000379:methods; D008297:Male; D011817:Rabbits; D016159:Tumor Suppressor Protein p53 / Q000032:analysis* / Q000235:genetics / Q000378:metabolism
D016159:Tumor Suppressor Protein p53